[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100610071":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":23,"centralContacts":38,"locations":44,"responsibleParty":153,"collaborators":155,"id":159,"slug":23,"hasResults":160,"nctId":161,"briefTitle":162,"officialTitle":163,"acronym":23,"eligibilityCriteria":164,"healthyVolunteers":160,"sex":165,"minAge":166,"maxAge":23,"enrollmentInfo":167,"targetDuration":23,"studyType":170,"phases":171,"briefSummary":173,"conditions":174,"keywords":177,"overallStatus":182,"whyStopped":23,"lastUpdateSubmitDate":183,"lastUpdatePostDateStruct":184,"startDateStruct":187,"completionDateStruct":189,"leadSponsor":191,"locationsCount":192},{"fullName":5,"class":6},"Echosens","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Full Cohort","EXPERIMENTAL","This population will be defined by patients fulfilling all inclusion and exclusion criteria.",[13,14,15,16],"Device: FibroScan","Procedure: Right-sided Heart Catheterization","Procedure: Transthoracic echocardiography","Biological: Blood Sample Analysis",[18,24,29,33],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":23},"DEVICE","FibroScan","At Day 0: 1 FibroScan examination to collect Liver Stiffness Measurement (LSM)",[9],null,{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":23},"PROCEDURE","Right-sided Heart Catheterization","at Day 0: Right-sided Heart Catheterization (RHC) to measure Central Venous Pressure (CVP)",[9],{"type":25,"name":30,"description":31,"armGroupLabels":32,"otherNames":23},"Transthoracic echocardiography","at Day 0 assessment of cardiac function",[9],{"type":34,"name":35,"description":36,"armGroupLabels":37,"otherNames":23},"BIOLOGICAL","Blood Sample Analysis","At Day0: To assess baseline organ function that may impact participant safety, and blood samples for clinical laboratory tests",[9],[39],{"name":40,"role":41,"phone":42,"phoneExt":23,"email":43},"CAROLE MEILLEROUX, PharmD","CONTACT","+33622649277","carole.meilleroux@echosens.com",[45,62,77,92,107,123,138],{"facility":46,"status":23,"city":47,"state":48,"zip":49,"country":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"Keck Medicine of USC-Norris Healthcare Center - Transplant Clinic","Los Angeles","California","90033","United States",{"type":52,"coordinates":53},"Point",[54,55],-118.24368,34.05223,{"lat":55,"lon":54},[58],{"name":59,"role":41,"phone":23,"phoneExt":60,"email":61},"Michael Fong, MD","323-442-8437","michael.fong@usc.edu",{"facility":63,"status":23,"city":64,"state":65,"zip":66,"country":50,"cosmosGeoPoint":67,"geoPoint":71,"contacts":72},"University of Minnesota","Minneota","Minnesota","55455",{"type":52,"coordinates":68},[69,70],-95.98559,44.55885,{"lat":70,"lon":69},[73],{"name":74,"role":41,"phone":75,"phoneExt":23,"email":76},"Tamas Alexy, MD","612-626-1240","alexy001@umn.edu",{"facility":78,"status":23,"city":79,"state":80,"zip":81,"country":50,"cosmosGeoPoint":82,"geoPoint":86,"contacts":87},"Medical University of South Carolina","Charleston","South Carolina","29425",{"type":52,"coordinates":83},[84,85],-79.93275,32.77632,{"lat":85,"lon":84},[88],{"name":89,"role":41,"phone":90,"phoneExt":23,"email":91},"Michele Esposito, MD","843-792-1105","espositm@musc.edu",{"facility":93,"status":23,"city":94,"state":95,"zip":96,"country":50,"cosmosGeoPoint":97,"geoPoint":101,"contacts":102},"University of Texas Southwestern Medical Center - Clinical Heart and Vascular Center - West Campus Building 3 Location","Dallas","Texas","75390",{"type":52,"coordinates":98},[99,100],-96.80667,32.78306,{"lat":100,"lon":99},[103],{"name":104,"role":41,"phone":105,"phoneExt":23,"email":106},"Ambarish Pandey, MD, MSCS, FAHA","214-645-2101","ambarish.pandey@utsouthwestern.edu",{"facility":108,"status":23,"city":109,"state":110,"zip":111,"country":112,"cosmosGeoPoint":113,"geoPoint":117,"contacts":118},"Centre Hospitalier Universitaire (CHU) de Rennes - Hopital de Pontchaillou","Rennes","Ile Et Vilaine","35000","France",{"type":52,"coordinates":114},[115,116],-1.67431,48.11109,{"lat":116,"lon":115},[119],{"name":120,"role":41,"phone":121,"phoneExt":23,"email":122},"Erwan Donal, MD","33617708567","erwan.donal@chu-rennes.fr",{"facility":124,"status":23,"city":125,"state":23,"zip":126,"country":127,"cosmosGeoPoint":128,"geoPoint":132,"contacts":133},"Deutsches Herzzentrum der Charité (DHZC) - Klinik fuer Herz-, Thorax- und Gefaesschirurgie","Berlin","13353","Germany",{"type":52,"coordinates":129},[130,131],13.41053,52.52437,{"lat":131,"lon":130},[134],{"name":135,"role":41,"phone":136,"phoneExt":23,"email":137},"Felix Schoenrath, MD","4.93046E+11","felix.schoenrath@dhzc-charite.de",{"facility":139,"status":23,"city":140,"state":141,"zip":23,"country":142,"cosmosGeoPoint":143,"geoPoint":147,"contacts":148},"Uniwersytet Medyczny im. Piastow Slaskich we Wroclawiu, Instytut Chorob Serca","Wroclaw","Basse-Silésie","Poland",{"type":52,"coordinates":144},[145,146],17.03006,51.10286,{"lat":146,"lon":145},[149],{"name":150,"role":41,"phone":151,"phoneExt":23,"email":152},"Jan Biegus, MD","48606674114","janbiegus@gmail.com",{"type":154,"investigatorFullName":23,"investigatorTitle":23,"investigatorAffiliation":23,"oldNameTitle":23,"oldOrganization":23},"SPONSOR",[156],{"name":157,"class":158},"Syneos Health","OTHER","100610071",false,"NCT07222813","Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)","Performance of Liver Stiffness Measurement (LSM) by FibroScan® for the Diagnosis of Elevated Central Venous Pressure (CVP)","Inclusion Criteria:\n\n1. Have read, understood, and signed the informed consent form (ICF)\n2. Be ≥18 years of age at the time of screening\n3. Have suspected or diagnosed acute or chronic HF and be scheduled to undergo right-sided cardiac catheterization\n\nExclusion Criteria:\n\n1. Inability to consent\n2. Chronic liver disease (self-reported alcohol use \\>14 drinks\u002Fweek in females and \\>21 drinks\u002Fweek in males), positive hepatitis C virus serology, positive hepatitis B surface antigen, autoimmune hepatitis, hemochromatosis, or cholestatic disease)\n3. BMI \\>40 kg\u002Fm2\n4. Fontan-type circulation\n5. Ascites\n6. Heart transplantation\n7. Pregnancy, breastfeeding, or intent to become pregnant during the study\n8. Intent to donate\u002Fbank or retrieve eggs (ova, oocytes) or donate sperm during the study","ALL","18 Years",{"count":168,"type":169},149,"ESTIMATED","INTERVENTIONAL",[172],"NA","This is a pivotal, global, prospective, cross-sectional, multicentric clinical investigation designed to explore a non-invasive, reliable alternative to invasive, catheter-based hemodynamic assessments, which are associated with procedural risks and limited applicability in certain participant populations.",[175,176],"Heart Failure","Heart Failure - NYHA II - IV",[178,179,180,181],"Fibroscan","Vibration Control Transient Elastography","Liver Stiffness Measurement","Guided VCTE","NOT_YET_RECRUITING","2025-10-28",{"date":185,"type":186},"2025-10-30","ACTUAL",{"date":188,"type":169},"2026-01-15",{"date":190,"type":169},"2027-01-15",{"name":5,"class":6},7]